This evening, Mark Smithyes, MBA, President of Janus Life Sciences Consulting, explores how reimbursement, health technology assessment and economic evidence influence medtech adoption and commercialization. Mark has spent more than 30 years in the life sciences and founded Janus in 2017. His session will help early-stage innovators understand what payers look for and start gathering the evidence they’ll need to make the case for their technology.
Mark Smithyes joins Sunnybrook’s Medventions 2026 Lecture Series
Next
Next